Advancedmolecular

microRNA Gene Regulation

Overview

microRNAs are ~22-nt RNAs that silence genes post-transcriptionally: transcribed as pri-miRNAs, cropped by Drosha, exported, diced by Dicer, and loaded into RISC, where the seed sequence (nt 2-8) pairs with target 3' UTRs to block translation or degrade mRNA. Humans have ~2,000 miRNAs regulating most protein-coding genes; lin-4 (1993, Ambros/Schwartz) founded the field (Nobel 2024 to Ambros and Ruvkun).

Learning objectives

  • Outline miRNA biogenesis (Drosha, Dicer, RISC)
  • Explain seed-sequence targeting
  • Describe miRNA roles in development
  • Explain miRNA links to cancer

Biogenesis

Pol II transcribes pri-miRNA hairpins; Drosha-DGCR8 crops them to pre-miRNAs; Exportin-5 exports; Dicer trims to ~22-nt duplexes; one strand loads into Argonaute (RISC). The whole pathway is a repurposed antiviral RNAi system turned to endogenous gene regulation.

Drosha -> Dicer -> RISC

Two RNase III cuts convert a hairpin transcript into a gene-silencing guide.

Targeting by the seed

Nucleotides 2-8 (the seed) pair with complementary sites, usually in target 3' UTRs; perfect pairing favors mRNA cleavage (rare in animals), partial pairing blocks translation and recruits deadenylases. One miRNA targets hundreds of mRNAs; one mRNA is hit by many miRNAs: a dense regulatory network.

Many-to-many regulation

miRNAs fine-tune networks rather than switching single genes: rheostats, not on/off switches.

Development and physiology

lin-4 and let-7 time C. elegans larval transitions (the founding discovery); miR-1 drives muscle differentiation; miR-124 specifies neurons. Knockouts show developmental timing, stem-cell, and metabolic defects. Circulating miRNAs serve as disease biomarkers.

Pleiotropy is the rule

Each miRNA tunes hundreds of targets, so phenotypes are broad and context-dependent.

Cancer and therapy

OncomiRs (miR-21, miR-155) are overexpressed in tumors; tumor-suppressor miRNAs (let-7, miR-34) are lost. AntagomiRs (anti-miR oligonucleotides) and miRNA mimics are in clinical trials; miravirsen (anti-miR-122) showed the path in hepatitis C.

Therapeutic promise, delivery challenge

miRNA drugs work in principle; getting them into the right cells remains the hurdle.

Key points

  • miRNAs: ~22-nt guides made by Drosha/Dicer, acting through RISC
  • Seed sequence (nt 2-8) targets 3' UTRs: translational block or decay
  • One miRNA, hundreds of targets: network fine-tuning
  • OncomiRs vs tumor-suppressor miRNAs; antagomiR therapies in trials

Common misconceptions

✗ Myth: miRNAs destroy all their target mRNAs.

✓ Truth: Animal miRNAs usually repress translation/deadenylate; slicing needs near-perfect complementarity (common in plants).

✗ Myth: siRNAs and miRNAs are identical.

✓ Truth: Related but distinct: siRNAs are exogenous/perfect-match slicers; miRNAs are endogenous, partial-match tuners.

Practice questions

Q1. miRNA biogenesis requires, in order,
  1. Dicer then Drosha
  2. Drosha then Dicer
  3. RISC then Drosha
  4. Pol III only
Answer: B.

Nuclear Drosha crops pri-miRNA; cytoplasmic Dicer makes the mature duplex.

Q2. Target recognition depends mainly on the
  1. Whole miRNA
  2. Seed sequence (nt 2-8)
  3. 5' cap
  4. Poly-A tail
Answer: B.

Seed pairing with 3' UTR sites determines targeting.

Q3. The founding miRNA discovery was ___ in C. elegans
  1. miR-21
  2. lin-4
  3. let-7
  4. miR-122
Answer: B.

lin-4 (1993) was the first miRNA; let-7 followed and is conserved to humans.

Click a question to reveal the answer and explanation.

Frequently asked questions

What won the 2024 Nobel in Physiology or Medicine?

Ambros and Ruvkun, for discovering microRNAs (lin-4, let-7) and their role in post-transcriptional regulation.

How do miRNAs differ from siRNAs?

miRNAs: endogenous, partial complementarity, translational repression. siRNAs: often exogenous, perfect match, mRNA cleavage.

Why are circulating miRNAs biomarkers?

They are stable in blood (in vesicles/protein complexes) and their profiles shift characteristically in disease.